Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients &#8805;65 years old.

Doughty, Christopher T; Suh, Joome; David, William S; Amato, Anthony A; Guidon, Amanda C

Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients ≥65 years old.

Doughty, Christopher T; Suh, Joome; David, William S; Amato, Anthony A; Guidon, Amanda C.

Afiliación

Doughty CT; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Suh J; Harvard Medical School, Boston, Massachusetts, USA.
David WS; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Amato AA; Harvard Medical School, Boston, Massachusetts, USA.
Guidon AC; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Muscle Nerve ; 64(6): 651-656, 2021 12.

Article en En | MEDLINE | ID: mdl-34378210

Asunto(s)

Factores Inmunológicos; Miastenia Gravis; Anciano; Humanos; Factores Inmunológicos/efectos adversos; Miastenia Gravis/inducido químicamente; Miastenia Gravis/tratamiento farmacológico; Prednisona/efectos adversos; Estudios Retrospectivos; Rituximab/efectos adversos

Palabras clave

B-cell depletion; myasthenia gravis; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores Inmunológicos / Miastenia Gravis Tipo de estudio: Observational_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Muscle Nerve Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google